Clinical Trials in Nashville

Showing 16841-16860 of 20,298 trials

Dose Ranging Study

NCT01802723

Dose Ranging Study

Periumbilical Subcutaneous Adipose Tissue Reduction

Neothetics, Inc472 participantsStarted Feb 2013

Beverly Hills, California, United States • Encinitas, California, United States • Los Angeles, California, United States +19 more locations

COMPLETED< 1 mile

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca1,297 participantsStarted Sep 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tucson, Arizona, United States +104 more locations

Dose Ranging Study

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Find Trials by Condition in Nashville

Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Phase IIIB Subcutaneous Abatacept Monotherapy Study

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Effects of HQK-1001 in Patients With Sickle Cell Disease

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

The BRILLIANT Study

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme